Your browser doesn't support javascript.
loading
Epigenetic profiling in CD4+ and CD8+ T cells from Graves' disease patients reveals changes in genes associated with T cell receptor signaling.
Limbach, Maia; Saare, Mario; Tserel, Liina; Kisand, Kai; Eglit, Triin; Sauer, Sascha; Axelsson, Tomas; Syvänen, Ann-Christine; Metspalu, Andres; Milani, Lili; Peterson, Pärt.
  • Limbach M; Molecular Pathology, Institute of Biomedical and Translational Medicine, Tartu, Estonia.
  • Saare M; Molecular Pathology, Institute of Biomedical and Translational Medicine, Tartu, Estonia.
  • Tserel L; Molecular Pathology, Institute of Biomedical and Translational Medicine, Tartu, Estonia.
  • Kisand K; Molecular Pathology, Institute of Biomedical and Translational Medicine, Tartu, Estonia.
  • Eglit T; Department of Internal Medicine, University of Tartu, Tartu, Estonia; Internal Medicine Clinic, Tartu University Hospital, Tartu, Estonia.
  • Sauer S; Max-Planck Institute for Molecular Genetics, Berlin, Germany.
  • Axelsson T; Department of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Syvänen AC; Department of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Metspalu A; Estonian Genome Center, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.
  • Milani L; Estonian Genome Center, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia. Electronic address: lili.milani@ut.ee.
  • Peterson P; Molecular Pathology, Institute of Biomedical and Translational Medicine, Tartu, Estonia. Electronic address: part.peterson@ut.ee.
J Autoimmun ; 67: 46-56, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26459776
ABSTRACT
In Graves' disease (GD), a combination of genetic, epigenetic and environmental factors causes an autoimmune response to the thyroid gland, characterized by lymphocytic infiltrations and autoantibodies targeting the thyroid stimulating hormone receptor (TSHR) and other thyroid antigens. To identify the epigenetic changes involved in GD, we performed a genome-wide analysis of DNA methylation and enrichment of H3K4me3 and H3K27ac histone marks in sorted CD4+ and CD8+ T cells. We found 365 and 3322 differentially methylated CpG sites in CD4+ and CD8+ T cells, respectively. Among the hypermethylated CpG sites, we specifically found enrichment of genes involved in T cell signaling (CD247, LCK, ZAP70, CD3D, CD3E, CD3G, CTLA4 and CD8A) and decreased expression of CD3 gene family members. The hypermethylation was accompanied with decreased levels of H3K4me3 and H3K27ac marks at several T cell signaling genes in ChIP-seq analysis. In addition, we found hypermethylation of the TSHR gene first intron, where several GD-associated polymorphisms are located. Our results demonstrate an involvement of dysregulated DNA methylation and histone modifications at T cell signaling genes in GD patients.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Transducción de Señal / Enfermedad de Graves / Subgrupos de Linfocitos T / Epigénesis Genética Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Transducción de Señal / Enfermedad de Graves / Subgrupos de Linfocitos T / Epigénesis Genética Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2016 Tipo del documento: Article